These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8605099)

  • 21. Cyclin D1 gene amplification and overexpression are present in ductal carcinoma in situ of the breast.
    Vos CB; Ter Haar NT; Peterse JL; Cornelisse CJ; van de Vijver MJ
    J Pathol; 1999 Feb; 187(3):279-84. PubMed ID: 10398079
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic divergence in the clonal evolution of breast cancer.
    Fujii H; Marsh C; Cairns P; Sidransky D; Gabrielson E
    Cancer Res; 1996 Apr; 56(7):1493-7. PubMed ID: 8603391
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Allelic loss at BRCA1, BRCA2, and adjacent loci in relation to TP53 abnormality in breast cancer.
    Tseng SL; Yu IC; Yue CT; Chang SF; Chang TM; Wu CW; Shen CY
    Genes Chromosomes Cancer; 1997 Dec; 20(4):377-82. PubMed ID: 9408754
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genomic instability demonstrates similarity between DCIS and invasive carcinomas.
    Heaphy CM; Bisoffi M; Joste NE; Baumgartner KB; Baumgartner RN; Griffith JK
    Breast Cancer Res Treat; 2009 Sep; 117(1):17-24. PubMed ID: 18785004
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of aberrant gene expression during breast ductal carcinoma
    Song G; He L; Yang X; Yang Y; Cai X; Liu K; Feng G
    J Int Med Res; 2020 Jan; 48(1):300060518815364. PubMed ID: 30712460
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detailed deletion mapping of chromosome segment 17q12-21 in sporadic breast tumours.
    Nagai MA; Yamamoto L; Salaorni S; Pacheco MM; Brentani MM; Barbosa EM; Brentani RR; Mazoyer S; Smith SA; Ponder BA
    Genes Chromosomes Cancer; 1994 Sep; 11(1):58-62. PubMed ID: 7529047
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A breast/ovarian cancer patient with germline mutations in both BRCA1 and BRCA2.
    Ramus SJ; Friedman LS; Gayther SA; Ponder BA; Bobrow L; van der Looji M; Papp J; Olah E
    Nat Genet; 1997 Jan; 15(1):14-5. PubMed ID: 8988162
    [No Abstract]   [Full Text] [Related]  

  • 28. Loss of heterozygosity in ductal carcinoma in situ of the breast.
    Stratton MR; Collins N; Lakhani SR; Sloane JP
    J Pathol; 1995 Feb; 175(2):195-201. PubMed ID: 7738715
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Loss of heterozygosity and allelic imbalance in apocrine metaplasia of the breast: microdissection microsatellite analysis.
    Selim AG; Ryan A; El-Ayat G; Wells CA
    J Pathol; 2002 Mar; 196(3):287-91. PubMed ID: 11857491
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic pathways in the evolution of breast ductal carcinoma in situ.
    Farabegoli F; Champeme MH; Bieche I; Santini D; Ceccarelli C; Derenzini M; Lidereau R
    J Pathol; 2002 Mar; 196(3):280-6. PubMed ID: 11857490
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of chromosome aneuploidy in tissue sections of preinvasive breast carcinomas using interphase cytogenetics.
    Visscher DW; Wallis TL; Crissman JD
    Cancer; 1996 Jan; 77(2):315-20. PubMed ID: 8625240
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Frequent promoter hypermethylation of BRCA2, CDH13, MSH6, PAX5, PAX6 and WT1 in ductal carcinoma in situ and invasive breast cancer.
    Moelans CB; Verschuur-Maes AH; van Diest PJ
    J Pathol; 2011 Oct; 225(2):222-31. PubMed ID: 21710692
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Allele imbalance, or loss of heterozygosity, in normal breast epithelium of sporadic breast cancer cases and BRCA1 gene mutation carriers is increased compared with reduction mammoplasty tissues.
    Larson PS; Schlechter BL; de las Morenas A; Garber JE; Cupples LA; Rosenberg CL
    J Clin Oncol; 2005 Dec; 23(34):8613-9. PubMed ID: 16314623
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence for a tumor suppressor gene distal to BRCA1 in prostate cancer.
    Williams BJ; Jones E; Zhu XL; Steele MR; Stephenson RA; Rohr LR; Brothman AR
    J Urol; 1996 Feb; 155(2):720-5. PubMed ID: 8558713
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Allelic imbalance on chromosomes 13 and 17 and mutation analysis of BRCA1 and BRCA2 genes in monozygotic twins concordant for breast cancer.
    Försti A; Luo L; Vorechovsky I; Söderberg M; Lichtenstein P; Hemminki K
    Carcinogenesis; 2001 Jan; 22(1):27-33. PubMed ID: 11159737
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ductal carcinoma in situ in breast carcinogenesis.
    van Diest PJ
    J Pathol; 1999 Mar; 187(4):383-4. PubMed ID: 10398095
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Possible Prognostic Role of HER2/Neu in Ductal Carcinoma In Situ and Atypical Ductal Proliferative Lesions of the Breast.
    Daoud SA; Ismail WM; Abdelhamid MS; Nabil TM; Daoud SA
    Asian Pac J Cancer Prev; 2016; 17(8):3733-6. PubMed ID: 27644608
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of RASSF1A aberrant promoter hypermethylation in sputum from chronic smokers and ductal carcinoma in situ from breast cancer patients.
    Honorio S; Agathanggelou A; Schuermann M; Pankow W; Viacava P; Maher ER; Latif F
    Oncogene; 2003 Jan; 22(1):147-50. PubMed ID: 12527916
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Allelic loss on a chromosome 17 in ductal carcinoma in situ of the breast.
    Radford DM; Fair K; Thompson AM; Ritter JH; Holt M; Steinbrueck T; Wallace M; Wells SA; Donis-Keller HR
    Cancer Res; 1993 Jul; 53(13):2947-9. PubMed ID: 8391383
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High levels of allele loss at the FHIT and ATM genes in non-comedo ductal carcinoma in situ and grade I tubular invasive breast cancers.
    Man S; Ellis IO; Sibbering M; Blamey RW; Brook JD
    Cancer Res; 1996 Dec; 56(23):5484-9. PubMed ID: 8968105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.